几种药物对子宫内膜容受性影响的研究  

The Research Progress of Several Chinese and Western Medicine on Endometrial Receptivity

作　　者：朱虹[1] 王芳[2] 李冰[2] 

机构地区：[1]广东医学院,广东省湛江市524023 [2]广州医学院第三附属医院

出　　处：《国际妇产科学杂志》2009年第5期360-363,共4页Journal of International Obstetrics and Gynecology

基　　金：广东省中医药局课题资助(2007358);广东省自然科学基金课题资助(5002464)

摘　　要：子宫内膜容受性是子宫内膜接受胚胎着床的一种综合状态,与胚胎植入率及妊娠率密切相关。随着辅助生殖技术的发展,促排卵药物应用的成熟,对不孕症的诊治也上升到新的高度,提高胚胎植入率及妊娠率成为关键。控制性超排卵药物会影响子宫内膜的生长,改变子宫内膜容受性。通过总结几种中西药物对子宫内膜容受性的影响,以期为提高辅助生殖技术的成功率提供参考。Endometrial receptivity is an integrated state of endometrium acceptable embryo implantation, which is closely related to embryo implantation rate and pregnancy rate. In recent years, with the development of assisted reproductive technology, the application of ovulation induction drugs, diagnosis and treatment of infertility have increased to a new level, the key point is to improve embryo implantation rate and pregnancy rate. Controlled ovarian hyperstimulation drugs will affect the growth of the endometrium, and change the endometrial receptivity. In this paper, we summarize of several Chinese and western medicine on endometrial receptivity, with a view to provide reference to improve the success rate of assisted reproductive technology.

关 键 词：子宫内膜容受性 药物 体外受精 植入率 妊娠率 

分 类 号：R714.8[医药卫生—妇产科学]